Dorset County Hospital Cancer of Unknown Primary (CUP) Service

Slides:



Advertisements
Similar presentations
A Case Study GP Masterclass Catherine Dale, RN, BSc Cancer Care
Advertisements

Cancer of Unknown Primary
Cancer of Unknown Primary Dr Chris Jones Consultant Medical Oncologist North of England Cancer Network Annual Conference 20 September 2013.
British Association of Urological Surgeons Metastatic Prostate Cancer Guidelines.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
FAST TRACK REFERRALS Haematology Dr.V Tandon Consultant Haematologist
Managing the patients experience of radical surgery with HIPEC for stage 4 colorectal disease Jackie Rodger Lead Colorectal Nurse Specialist Carol Baird.
Joint Hospital Surgical Grand Round 21 st July, 2012 RH.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
Acute Oncology Service (AOS) Monday – Friday 8am – 4pm Bleep: 946 T: x5726 F: Dr Nicola Beech Dr Jillian Noble Dr Susannah.
Breast cancer patient pathway
How to manage suspected cancer
Go with the flow: the changing pathways in Urology CATS Urology Clinical Assessment & Treatment Service UROLOGY CATS.
Acute Oncology Dr Nicola Storey.
‘Let’s get it right - Referral for suspected Cancer’
Anne Snow, Lead Cancer Nurse Dr Andrew Woolley – Consultant Physician.
Radiology “Dos and Don’ts” Clinical Governance Medical Division 18 July 2013.
The Wellington Experience Paul Smith and Dr A. O'Donnell Cancer Care Co-ordination.
ONE YEAR EXPERIENCE OF A “ SAFETY NET” PROTOCOL FOR ABNORMAL CHEST RADIOGRAPHS (CXR) H Singh, SCO Taggart, PM Turkington, K Peplow, R Chisholm, BR O’ Driscoll.
National Optimal Clinical Pathway for suspected and confirmed lung cancer: Referral to treatment Note: this was previously circulated for discussion as.
National Clinical Pathway for suspected and confirmed lung cancer:
SMDT SMDT SMDT Synchronous Metastasis on Staging/Surveillance
Risk of stroke at 3 months6 Expected Strokes at 3 months
CASE 1: Management of metastatic disease in a resource-limited setting
Consultant Medical Oncologist
Cancer Audit Stourport Health Centre Feb 2016
Upper Gastrointestinal Cancers Top ⑩ Tips
Camden Two Week Wait Referrals Feedback
‘Piloting change’ report on the Multi Disciplinary Diagnostic centre
TYA Designated Hospital perspective
EOL care Closing the Gap 2b.
Dr. Rebecca Croft SpR Palliative Medicine.
BREAST CANCER ONCOLOGY NAVIGATION SERVICE
SWAG Cancer Alliance Update
Jane E Scullion Respiratory Nurse Consultant
Recognition and Referral of Suspected cancer NICE NG12 – 2Week Wait
Dr James Carlton, Medical Adviser
Learning About PET/CT Scans:
Mr Michael Thomas, Colorectal Cancer SSG, 27th June 2018
AN OVERVIEW OF THE BONE METASTASES PROGRAM
Pathway for patients with suspected Breast Cancer
Six stage journey When diagnosed with a brain tumour.
Katie’s story: Advanced colorectal cancer
Teams Home Medical Home Community Hospital.
Pathway for patients with suspected Skin Cancer
Pathway for patients with suspected Upper GI (OG) Cancer
Supporting patients at clinic and beyond
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Pathway for patients with suspected colorectal cancer
Lung Cancer Screening Sandra Starnes, MD Professor of Surgery
Lung Cancer Pathway Dr Heather Harris - Consultant Radiologist
Myeloma: Symptoms to diagnosis Can we do better?
2015/16 National Cancer Patient Experience Survey
General Imaging Information
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Pathway for patients with suspected HPB Cancer Inter Provider Transfer
NHS South Tees CCG Rapid Specialist Opinion (RSO)
Calculate Well’s score for PE (BOX1)
Service Delivery Group – January 2019
Early and locally advanced breast cancer
Pathway for patients with suspected Breast Cancer
Living With & Beyond Cancer: SWAG Breast SSG Update
PPG Meeting on general practice is changing
A case of localized Prostate Cancer Marije Hamaker.
Airedale NHS Foundation Trust
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Standardised follow-up
Urology cancer update for primary care
Urology Cancer Update for Primary Care 29 June 2019
GP access to body CT for suspected malignancy
Presentation transcript:

Dorset County Hospital Cancer of Unknown Primary (CUP) Service JW. 10/11/15

Classification MUO – Malignancy of unknown origin. pCUP – Provisional Cancer of Unknown Primary Confirmed cCUP – No primary site found Continuing investigations to find the primary are only carried out if 1. the patient is fit enough to undergo treatment if the primary is found. 2.The results are likley to affect a treatment decision. 3.The patient understands why the investigations are being performed and the potential risks and benefits in investigation and treatment.

DCH CUP MDT Core Members: Dr Richard Osborne – (MDT Lead) Consultant Medical Oncologist Dr Tom Marsh – Consultant Radiologist Dr Teresa Thomas - Consultant Histopathologist Dr Sandra Pepper – Speciality Doctor, Hospital Palliative Care Team Ann Dixon - Palliative Care Specialist Nurse Jane Wraight – CUP (and Upper GI) CNS Ellie Goff – MDT Facilitator Much smaller MDT than most, and numbers of patients discussed are smaller than other sites however, because of the often complex nature of them, discussions can sometimes be more lengthy. MDTs are held on a Thursday 11.45 and we also have a “virtual” MDT on Tuesdays when our MDT Facilitator, Dr Osborne and I get together to review any patients newly referred and any undergoing investigation.

Accessing the CUP service Fast track referral In-patient referral Inter-MDT referral from other cancer sites Referral to members of the MDT e.g. Palliative care team Via radiology reporting Patients come from all over the place and all different. As soon as a patient is referred to the service, one of the CUP team will review, usually contacting Dr Osborne, getting rapid guidence over next steps. This may be getting specific tests requested or preventing further tests if they are not appropriate. – One of the most important aspects from my point of view is to try and meet or speak to the patient and identify myself as their key worker. sometimes it is more appropriate for the palliative care team to be their key worker.

CUP – Peer Review Cancer of Unknown Primary is now being managed as all other site specific cancers. CUP is subject to peer review. This year we had internal validation and were pleased to have very positive feedback. In 2016 we will be externally peer reviewed with a National Team on site on 4th April 2016.

Metastatic site cCUP 67% (6) Peritoneal (9) Ovarian 22% (2) Lung 11% (1) I have to admit that these next two slides are actually Poole’s data, but as they are similar to West Dorset’s and the graphs give a good demonstration of the different primary sites found and those that are confirmed CUP cCUP 63% (5) Lymph Node(s) (8) Ovarian 13% (1) Haem 25% (2)

Metastatic site Liver (14) Bone (13) cCUP 71% (10) Small Bowel 7% (1) Pancreas 21% (3) cCUP 25% (3) Lung 25% (3) Pancreas 15% (2) Bone (13) Renal 15% (2) Ovarian 8% (1) Prostate 8% (1) Small Bowel 7% (1)

DCH CUP Patient timeline (W165445) PRESENTING SYMPTOMS; Referred to Urology by GP with increasing Urinary tract symptoms. Seen in Urology O.P 2.04.15 Previous heavy smoker stopped 3 months ago. Serum PSA 3.04.14 = 6.04. Serum PSA 18.11.14 = 8.07 MRI & Urology MDT planned. 14/04/15 MRI PELVIS 15/04/15 Urology MDT: Discuss at following days MDT 16/04/15 Specialist Urology MDT: MR showed extensive bone mets – for urgent CT (requested) 21/04/15 CT scan chest abdo pelvis 22/04/14 Urology MDT – CT shows bone mets. No primary. For TRUS and biopsies re-discuss at MDT following this. TRUS & biopsy requested 5/05/15 Prostate biopsy 13/05/15 Urology MDT: No primary identified. Normal trans rectal biopsies. For CT of right pubic bone. Refer to CUP MDT 13/06/15 Prostate biopsy reported no malignancy. For bone biopsy right pubic bone. Referred to CUP MDT 14/05/15 CUP MDT - Imaging of MRI and CT Remain under Urology team pending bone biopsy 3/06/15 Urology MDT: TRUS biopsies do not show any malignancy but has metastatic disease. Query origin – CUP MDT tomorrow 04/06/15 CUP MDT - Await bone biopsy. CUP team take over management, For femoral X-Rays to assess fracture risk. Repeat LFTs calcium and U&Es. for Dr Osborne OPA. 11/06/15 CUP MDT - Possible risk of fracture. For urgent Ortho opinion. Biopsy delayed deliberately in case Ortho procedure provided material 12/06/15 Orth opinion - no immediate fracture risk. For analgesia and observe 02/07/15 bone biopsy 09/07/15 CUP MDT - Histology pubic bone suggests diffuse large B-cell lymphoma – referred to Haematology. This demonstrates the complexity of some patients pathway, this patient was discussed at 8 MDTs – his pathway seemed frustratingly slow at times. As Key worker, This is a 77 year old man. I was able to speak to his GP on 13th May – same days as MDT. This enabled out CUP discussion the following day to have greater insight into this man, his understanding and general wellbeing. He was seen in the heamatology outpatients on 10th July and I was able to havdover the keyworker role to the haematology CNS